Aileron Therapeutics Inc (ALRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 1,992 | 5,011 | 4,703 | 6,482 | 8,041 |
| Operating Income | -1,992 | -5,011 | -4,703 | -6,482 | -8,041 |
| Other Income | 205 | 232 | 156 | 114 | 49 |
| Pre-tax Income | -1,787 | -4,779 | -4,547 | -6,368 | -7,992 |
| Net Income Continuous | -1,787 | -4,779 | -4,547 | -6,368 | -7,992 |
| Net Income | $-1,787 | $-4,779 | $-4,547 | $-6,368 | $-7,992 |
| EPS Basic Total Ops | -0.39 | -1.05 | -1.00 | -1.40 | -1.76 |
| EPS Basic Continuous Ops | -0.39 | -1.05 | -1.00 | -1.40 | -1.76 |
| EPS Diluted Total Ops | -0.39 | -1.05 | -1.00 | -1.40 | -1.76 |
| EPS Diluted Continuous Ops | -0.39 | -1.05 | -1.00 | -1.40 | -1.76 |
| EPS Diluted Before Non-Recurring Items | -0.39 | -0.82 | N/A | -1.40 | N/A |
| EBITDA(a) | $-2,032 | $-5,071 | $-4,783 | $-6,503 | $-8,017 |